Ponicidin and Oridonin Are Responsible for the Antiangiogenic Activity of Rabdosia rubescens, a Constituent of the Herbal Supplement PC SPES-Reference-Cited by-同舟云学术

Ponicidin and Oridonin Are Responsible for the Antiangiogenic Activity of Rabdosia rubescens, a Constituent of the Herbal Supplement PC SPES

Published:2003-12-20 Issue:1 Volume:67 Page:2-4
ISSN:0163-3864
Container-title:Journal of Natural Products
language:en
Short-container-title:J. Nat. Prod.

Author:

Meade-Tollin Linda C.¹,Wijeratne E. M. Kithsiri¹,Cooper Deborah¹,Guild Mischa¹,Jon Edlyn¹,Fritz Anne¹,Zhou Guang-Xiong¹,Whitesell Luke¹,Liang Jing-yu¹,Gunatilaka A. A. Leslie¹

Affiliation:

1. Southwest Center for Natural Products Research and Commercialization, Office of Arid Lands Studies, College of Agriculture and Life Sciences, University of Arizona, 250 E. Valencia Road, Tucson, Arizona 85706-6800, Departments of Surgery and Pediatrics, Arizona Health Sciences Center, University of Arizona, Tucson, Arizona 85724, and Department of Phytochemistry, China Pharmaceutical University, Nanjing 10003, People's Republic of China

Publisher

American Chemical Society (ACS)

Subject

Organic Chemistry,Complementary and alternative medicine,Drug Discovery,Pharmaceutical Science,Pharmacology,Molecular Medicine,Analytical Chemistry

Link

https://pubs.acs.org/doi/pdf/10.1021/np0304114

Reference24 articles.

1. Use of PC-SPES, a commercially available supplement for prostate cancer, in a patient with hormone-naive disease

2. Clinical and Biologic Activity of an Estrogenic Herbal Combination (PC-SPES) in Prostate Cancer

3. PC-SPES, a dietary supplement for the treatment of hormone-refractory prostate cancer

Cited by 63 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Recent Developments in the Syntheses of C‐20‐Oxygenated ent‐Kaurane Diterpenoids;ChemPlusChem;2024-03-19

2. Oridonin from Rabdosia rubescens: An emerging potential in cancer therapy – A comprehensive review;Food Science & Nutrition;2024-02

3. Novel Products as Promising Therapeutic Agents for Angiogenesis Inhibition;Current Drug Delivery;2024-01-09

4. Research Progress and Future Development Potential of Oridonin in Pharmacological Activities;Current Molecular Pharmacology;2023-11

5. HPLC Determination of Anti-cancer Components Isolated from Rabdosia rubescens;PHARMACOGN MAG;2022